Full-text search

Results for “Aspreva Pharmaceuticals”

Search across the indexed text of every released document.

44 documents found

Times Square Tower
document TEXT-001-HOUSE_OVERSIGHT_024003.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…rds of Cerexa (NLV-I company acquired by Forest Laboratories), Stromedix, Inc. (NLV-I company acquired by Biogen Idec), Aspreva Pharmaceuticals (NASDAQ: ASPV, acquired by Galenica, Inc.), Phase Forward (NASDAQ: PFWD, acquired by Oracle), and Pathology Partners (acquired by Caris...

COLLABORATIVE INSIGHTS February 25, 2019
document IMAGES-008-HOUSE_OVERSIGHT_024917.txt Feb 25, 2019 House Oversight Committee — Epstein Estate Records (Nov 2025)

COWEN COLLABORATIVE INSIGHTS February 25, 2019 ADDENDUM Stocks Mentioned In Important Disclosures Ticker Company Name WEED Canopy Growth Corporation GWPH GW Pharmaceuticals Plc TLRY Tilray TPB Turning Point Brands Important Disclosures and Information Relating to Cowen Wash...

Sprout Capital IX, L.P. (Healthcare Technology Portfolio)
document IMAGES-007-HOUSE_OVERSIGHT_024102.txt Mar 31, 2014 House Oversight Committee — Epstein Estate Records (Nov 2025)

…ics 29.3 Affymax, Inc. Therapeutics 2001 B72 17.9 - 17.9 0.48 Aspire Medical Healthcare Devices 2004 7A 0.6 - 0.6 0.07 Aspreva Pharmaceuticals Therapeutics 2004 23.2 151.7 - 151.7 6.54 Aureon Biosciences, Inc. Diagnostics & Infrastructure 2001 34.1 0.8 - 0.8 0.02 Auxilium Pharma...

molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the
document IMAGES-007-HOUSE_OVERSIGHT_024023.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

…rds of Cerexa (NLV-I company acquired by Forest Laboratories), Stromedix, Inc. (NLV-I company acquired by Biogen Idec), Aspreva Pharmaceuticals (NASDAQ: ASPV, acquired by Galenica, Inc.), Phase Forward (NASDAQ: PFWD, acquired by Oracle), and Pathology Partners (acquired by Caris...

Mark Penn*1g% Corp VP of Strategic Projects (reports to the CEO)
document IMAGES-004-HOUSE_OVERSIGHT_017579.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

*Mark Penn*1g% Corp VP of Strategic Projects (reports to the CEO), Microsoft. Fmr CEO, Burson-Marsteller. President, of polling firm Penn, Schoen and BerlandAssociates. Fmr Chief Strategist, Hillary Clinton for President 2008. Author, Microtrends. Fmr pollster to President Clinto...

 60 Years of Investigative Satire
document TEXT-001-HOUSE_OVERSIGHT_015032.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

 60 Years of Investigative Satire: The Best of Paul Krassner Introduction by Andy Borowitz Blurb by Art Spiegelman Click on this for a High Res Photo. What They Say About the Author “Paul’s own writing, in particular, seemed daring and ad...

Fwd: Invite to Dialog 2014 (16 months away)
email TEXT-001-HOUSE_OVERSIGHT_013484.txt Nov 28, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Ian Osborne Sent: 11/28/2012 5:55:14 PM To: Jeffrey Epstein [[email protected]] Subject: Fwd: Invite to Dialog 2014 (16 months away) Importance: High Same shit. Peter doesn't even attend. I will tell him that he should stop them using his name. Begin forwarded message:...

Ann Lewis - President, NoLimits. Fmr Director of Communications to the U.S. President (1997-2000)
document IMAGES-002-HOUSE_OVERSIGHT_013487.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Jonathan Levin — Prof and Chair of Dept of Economics, Stanford. 2011 Winner of the John Bates Clark Medal. Ann Lewis - President, NoLimits. Fmr Director of Communications to the U.S. President (1997-2000). Rob LoCasio — CEO, LivePerson (NASDAQ: LSPN). Jeremy Liew — GP, LightSpee...

11/28/2012 5:28:55 PM
email TEXT-001-HOUSE_OVERSIGHT_017581.txt Nov 28, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Sent: To: Subject: 11/28/2012 5:28:55 PM Jeffrey Epstein [[email protected]] Re: Invite to Dialog 2014 (16 months away) Importance: High So let me understand. You are suggesting tourism? Sent from my Verizon Wireless BlackBerry From: Jeffrey Epstein <[email protected]...